Skip to content

BCS Glucose Colorimetric Test

by Bioclinical Systems, Inc.

510(k) K850257

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK850257 Date5 Mar 1985ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
CGA
Device Class
Class II
Regulation
21 CFR Part 862.1345
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The BCS Glucose Colorimetric Test is a glucose oxidase-based device used for the quantitative determination of glucose in clinical specimens. It is classified as a Class II medical device under the Clinical Chemistry specialty.

The device received traditional 510(k) clearance from the FDA (K850257) on March 5, 1985, and is substantially equivalent to a legally marketed predicate device. It is manufactured by Bioclinical Systems, Inc. and is intended for use in clinical laboratory settings.

Other devices from Bioclinical Systems, Inc.

See all devices from Bioclinical Systems, Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical purpose does the BCS Glucose Colorimetric Test serve?

    It provides a quantitative determination of glucose concentration in patient specimens using a glucose oxidase reaction, allowing laboratories to monitor blood glucose levels for diagnosis and management of metabolic disorders.

  • Is the test supplied as a single‑use kit or can it be reused?

    The device is intended for single‑use in a clinical laboratory setting; each test unit is used once to ensure accurate results and to prevent cross‑contamination between samples.

  • How is the BCS Glucose Colorimetric Test classified and regulated?

    It is classified as a Class II medical device under the Clinical Chemistry specialty. The product received traditional 510(k) clearance (K850257) from the FDA on March 5 1985, indicating it is substantially equivalent to a legally marketed predicate.

  • What are the storage requirements for the test kits?

    The kits should be stored at the temperature recommended by the manufacturer, typically a controlled room temperature environment, and kept in their original packaging until use to maintain reagent stability.

  • Can the BCS Glucose Colorimetric Test be used outside of a laboratory?

    The device is intended for use in clinical laboratory settings only; it is not designed for point‑of‑care or home use because it requires specific instrumentation and controlled conditions to produce reliable quantitative results.